Organisation paid for research Program year 2025 Source: CMS Open Payments

The Orthopedic Foundation

Neither a doctor nor a teaching hospital

Research payments

$960,862

265 payments

Through program year 2025, The Orthopedic Foundation is reported as receiving $960,862 in research payments, across 265 payments.

By program year

6 rows
Year Kind Amount Payments
2025 Research $83,830 24
2024 Research $329,762 126
2023 Research $184,311 51
2022 Research $133,925 36
2021 Research $193,767 17
2020 Research $35,268 11

Breakdown

Who paid Research payments · program years 2020–2025
  1. AbbVie, Inc. $470,868 81 payments
  2. Smith+Nephew, Inc. $217,412 53 payments
  3. Neurocrine Biosciences, Inc. $97,055 2 payments
  4. Ipsen Innovation $88,420 100 payments
  5. Seaspine Orthopedics Corporation $54,014 17 payments
  6. Medtronic, Inc. $20,360 7 payments
  7. Stryker Corporation $6,000 2 payments
  8. Orthofix Medical, Inc. $4,134 1 payment
  9. ACADIA Pharmaceuticals Inc $2,600 2 payments
Studies the money was for Research payments · program years 2020–2025
  1. Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor $359,320 51 payments
  2. A Prospective Multi-center, Study to Evaluate the Safety and Effectiveness of REAL INTELLIGENCE CORI in unicondylar knee arthroplasty and total knee arthroplasty $136,496 31 payments
  3. Prospective, Open-label Clinical Study of Ingrezza (valbenazine) for the Treatment of Cervical Dystonia $97,055 2 payments
  4. Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study with Extension Phase to Evaluate the Efficacy and Safety of Dysport for the Prevention of Chronic Migraine in Adult Participants $74,794 86 payments
  5. M21-471 - Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor $63,098 9 payments
  6. A Prospective MultiCenter PreMarket Clinical Study to Evaluate the Performance of the REAL INTELLIGENCE Tensioner as an Accessory to the CORI Surgical System in Robotic Total Knee Arthroplasty Procedures $59,241 20 payments
  7. Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine $31,575 12 payments
  8. Medical Device Directive/Up-class $20,360 7 payments
  9. Data Capture relating to Journey II CR Total Knee System $20,000 1 payment
  10. Stronger Together Registry $15,912 6 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record